Subtransverse Interligamentary Block Versus Paravertebral Block for Quality of Recovery After Mastectomy

Recruiting now · Not applicable

Conditions studied: Quality of Recovery (QoR-15), Modified Radical Mastectomy

In brief

This prospective randomized controlled double blinded non-inferiority study will be carried out in Tanta University Hospitals for duration of 6 months from June 2026 to December 2026 on 60 female patients scheduled for unilatral modified radical mastectomy under general anesthesia.

Key facts

Study ID

NCT07647367

Run by

Tanta University

People needed

60

Starts

2026-06-20

Expected to finish

2027-01-01

Last updated by the study team

2026-08-04

Who can join

Age: 18 and older, up to 65. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Adult female patients aged 18 to 65 years with American Society of Anesthesiologists (ASA) Physical Status I - III, who were scheduled for unilateral MRM surgery under general anesthesia and able to understand and complete the QoR-15 questionnaire

You may not qualify if…

• • Patients declined to participate in the trial.
• History of allergy to the used local anesthetic (LA) drugs.
• Patients with cutaneous lesions at the needle entry point.
• Coagulopathy or current anticoagulant therapy contraindicating regional block.
• Patients with severe hepatic, renal, cardiac, or respiratory disease.
• Psychiatric or cognitive disorder interfering with QoR-15 assessment
• Chronic opioid use or chronic pain syndrome.
• Failed block.
• Morbid obesity (body mass index >40 kg/m2)
• Intraoperative major complications requiring postoperative ICU admission.
• Pregnancy

Where it is running

• Tanta university hospital — Tanta, Gharbia Governorate, Egypt (enrolling)
• Tanta university hospital — Tanta, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.